Article Information
History
- November 23, 2022.
Article Versions
- Version 1 (November 18, 2022 - 13:00).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Róisín M. Boggan1,
- Yi Shiau Ng1,
- Imogen G. Franklin1,
- Charlotte L. Alston1,2,
- Emma L. Blakely1,2,
- Boriana Büchner3,
- Enrico Bugiardini4,5,
- Kevin Colclough6,
- Catherine Feeney1,2,
- Michael G. Hanna4,5,
- Andrew T. Hattersley7,
- Thomas Klopstock3,8,9,
- Cornelia Kornblum10,
- Michelangelo Mancuso11,
- Kashyap A. Patel7,
- Robert D. S. Pitceathly4,5,
- Chiara Pizzamiglio4,5,
- Holger Prokisch12,13,
- Jochen Schäfer14,
- Andrew M. Schaefer1,
- Maggie H. Shepherd6,
- Annemarie Thaele15,
- Rhys H Thomas1,
- Doug M. Turnbull1,
- Cathy E. Woodward16,5,
- Gráinne S. Gorman1,
- Robert McFarland1,
- Robert W. Taylor1,2,
- Heather J. Cordell1,7 and
- Sarah J. Pickett1,*
- 1Wellcome Centre for Mitochondrial Research and Institute for Translational and Clinical Research, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK
- 2NHS Highly Specialised Services for Rare Mitochondrial Disorders, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK
- 3Department of Neurology, Friedrich-Baur-Institut, University Hospital of the Ludwig-Maximilians-University (LMU Klinikum), Munich, Germany
- 4Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK
- 5NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London WC1N 3BG, UK
- 6Exeter Genomics Laboratory, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
- 7Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK
- 8Munich Cluster for Systems Neurology (SyNergy), Munich, Germany
- 9German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
- 10Department of Neurology, Neuromuscular Diseases Section, University Hospital Bonn, Bonn, Germany
- 11Department of Clinical and Experimental Medicine, Neurological Institute, University of Pisa, Italy
- 12Institute of Human Genetics, School of Medicine, Technische Universität München, München, Germany
- 13Institute of Neurogenomics, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany
- 14Department of Neurology, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
- 15Department of Neurology, Martin-Luther-University Halle-Wittenberg, 06120 Halle (Saale), Germany
- 16Neurogenetics Unit, The National Hospital for Neurology and Neurosurgery, London, UK
- 17Population Health Sciences Institute, Newcastle University, UK
- ↵*To whom correspondence should be addressed: sarah.pickett{at}ncl.ac.uk
Posted November 23, 2022.
Defining the nuclear genetic architecture of a common maternally inherited mitochondrial disorder
